Results 151 to 160 of about 1,948,187 (170)

Luminescence anti‐counterfeiting: From elementary to advanced

Aggregate, 2021
Hongyue Zhang, Jihong Yu
exaly  

Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy

Cancer Cell, 2021
Clayton Yates, Alain Algazi, Marco Piva   +2 more
exaly  

Resistance Mechanisms to Anti-PD Cancer Immunotherapy

Annual Review of Immunology, 2022
Matthew Vesely, Lieping Chen
exaly  

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Cancer Cell, 2019
Serigne N Lo, Alexander M Menzies, Georgina V Long   +2 more
exaly  

Palladium coordination compounds as anti-viral, anti-fungal, anti-microbial and anti-tumor agents

Coordination Chemistry Reviews, 2009
S K Hadjikakou
exaly  

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

Annals of Oncology, 2015
Mario Lacouture, Karin Schindler, M A Postow   +2 more
exaly  

Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy

Annals of Oncology, 2016
H H M Yu, J S Weber, J S Weber
exaly  

Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription

Cell, 2019
Danielle L Swaney, Kuei-Ho Chen, Alan Davidson   +2 more
exaly  

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Annals of Oncology, 2019
Eduardo Vilar, S Kopetz, Christine Parseghian   +2 more
exaly  

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

Annals of Oncology, 2017
Ignacio Melero, Carlos Alfaro, Lieping Chen   +2 more
exaly